FEELM
FEELM, the flagship atomization tech brand belonging to SMOORE, today showcased the world's first ceramic coil disposable pod solution series, FEELM Max at Vaper Expo UK 2022 in Birmingham, UK. By launching the solution and showcasing its cutting-edge ceramic coil heating technology, FEELM is introducing ceramic coil to the emerging category of disposable vape.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20220527005197/en/
As a new category in the ascendant, the disposable vape has been growing in popularity since 2020. The market size of disposable (closed system) vaping product has grown to approximately USD2.125 billion in 2021, accounting for 22.7% of global vaping device market share; and it is expected to increase at a GAGR of over 28% from 2022 to 2026, being the fastest-growing category among all vaping products, according to the estimates of Frost & Suvillian. In 2022, the market size of disposable category is expected to reach USD2.72 billion, making up over 43% of closed system vaping products.
However, almost all the existing disposable vapes are equipped with cotton coil, which produces relatively large aerosol particles, leading to inefficient deposition of inhaled particles in the lungs, hence low nicotine delivery and satisfaction, as well as harshness in throat. Soft cotton coils are unable to form a stable structure, hence a high leakage rate and unpleasant burnt taste. Uneven heating of cotton coils could also cause a weak flavor consistency, so that vaping experience will fade gradually. Moreover, the selling points of most disposable vapes currently focus on large-mouth puff count, or rather, the huge number of puffs that the disposable will provide.
To address the three pain points, FEELM unveils the world's first ceramic coil disposable pod solution, FEELM Max is to disposable vapes what internal combustion engine is to airplanes, automobiles, ships, submarines, and trains. It aims to provide the next generation of disposable vapes with a stronger, more reliable and efficient atomization “engine”. Just like internal combustion engine, which features high thermal efficiency, light weight, compact size and maneuverability, marking the coming of the second industrial revolution; FEELM Max is expected to lead another ceramic coil revolution in the global vaping industry, since the launch of FEELM Air in January 2022.
This revolutionary vaping solution has largely improved e-liquid utilization by virtue of a cotton-free structure and microporous ceramic coil. Therefore, its puff number is increased by 25% with the same e-liquid volume, compared with traditional cotton coil disposable vapes. Besides, it can provide an unprecedented silky-smooth vaping experience, thanks to the ceramic coil, which generates smaller vaporized aerosol particles, thereby minimizing residue in throat. In contrast to cotton coil disposable vapes, the smoothness is improved also by 30%. This innovation also boasts extraordinary flavor consistency of over 95%, since ceramic coil can guarantee constant vapor production, so as to bring the same strong and great taste till the last puff.
In addition to the three major benefits, FEELM Max also features 46% increased overall harm reduction performance compared with cotton coil vapes, and ultra-low vaping leakage rate of less than 0.03%, empowered by Maze Leakage-proof Technology. The smaller vaporized aerosol particles generated by FEELM ceramic coil tend to deposit more in the lung, bringing greater and faster satisfaction. Meanwhile, FEELM's patented Flavor-Lock technology can bring tailored flavor release with terraced temperature zones.
In early 2022, FEELM Max has been adopted by a specialist vape retailer in the UK. In partnership with FEELM, this retailer has introduced an ultra-slim disposable product equipped with FEELM ceramic coil. Built to be lightweight and compact, this product is designed specifically for smoking cessation. In April, the two partners participated in VApril 2022, the world’s largest vaping awareness campaign to give away disposable vapes to adult smokers seeking to switch in London and Manchester.
At Vaper Expo UK 2022, FEELM has also showcased other industry-leading, pioneering disposable vaping solutions, for example, eco-friendly non-nicotine disposable e-cigarette and anti-dust mouthpiece hygienic e-cigarette. These two have been awarded Red Dot Awards for Product Design 2022 for their green product concepts and avant-garde design. Unlike traditional disposable e-cigarettes made of plastic, the external structure of eco-friendly non-nicotine disposable e-cigarette is composed of recyclable and reusable paper and aluminum foil while anti-dust mouthpiece hygienic e-cigarette features a twist nozzle to prevent the contact of mouthpiece with something unclean, with the product concept originated from lipsticks.
Another award-winning solution displayed at the event is FEELM Air, the world’s thinnest ceramic coil vape pod solution. In collaboration with its global clients, FEELM has demonstrated a series of vaping products of regional leading brands that adopt FEELM Air solution. Moreover, it will announce the 2022 timeline of commercial launch of FEELM Air on a global scale afterwards.
View source version on businesswire.com: https://www.businesswire.com/news/home/20220527005197/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
TreeFrog Therapeutics Announces Changes to Executive Committee With the Arrival of Mark Rothera as Chief Executive Officer & Board Member to Spearhead Next Phase of Growth16.12.2025 09:05:00 CET | Press release
TreeFrog Therapeutics, a French biotech focused on bringing regenerative medicine to millions through their proprietary cell technology, C-Stem™ is delighted to announce the appointment of skilled biotech leader, Mark Rothera, as Chief Executive Officer and Board member. He succeeds Frédéric Desdouits, who is stepping down after five years in the role. In the new leadership configuration, co-founders Kévin Alessandri and Maxime Feyeux will transition from daily operations to focus on their roles on the Board. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251215145193/en/ Mark Rothera, CEO TreeFrog Therapeutics Elsy Boglioli, Chair of the Board of TreeFrog Therapeutics, commented “On behalf of the Board, we are delighted to welcome Mark to TreeFrog. His 30+ years of biopharma leadership, including most recently, three biotech CEO roles in gene therapy and biologics, will be invaluable as we advance our Parkinson’s and liver
RoslinCT and Ayrmid Ltd. Announce Expansion of Strategic Partnership to Manufacture Omisirge® (omidubicel-onlv) for Second FDA-Approved Indication in Severe Aplastic Anemia (SAA)16.12.2025 09:00:00 CET | Press release
RoslinCT is performing technology transfer and will support commercial manufacture of Omisirge® for an additional indication following successful clinical trialsOmisirge® now FDA-approved for an expanded patient population in hematologyRoslinCT continues to support and advance multiple cell therapy projects at its Hopkinton, MA facility Ayrmid Ltd., the parent company of Gamida Cell Inc., a pioneering cell therapy company transforming cells into powerful therapeutics, and RoslinCT, a global leader in cell and gene therapy contract development and manufacturing, today announced the expansion of their strategic partnership to include the execution of a commercial supply agreement to support production of Omisirge® (omidubicel-onlv). Following positive clinical trial results, Omisirge® has received FDA approval for a second indication, broadening its use in the treatment of hematology patients. Under the commercial supply agreement, RoslinCT will complete technology transfer and support c
Echoworx Secures FSQS-Netherlands Certification, Strengthening Trust in Financial Data Protection16.12.2025 07:00:00 CET | Press release
Leading encryption provider deepens commitment to European financial sector with rigorous new supplier qualification, building on existing UK & Ireland certification. Echoworx, a global leader in email and data encryption, proudly announces it has achieved Financial Services Qualification System (FSQS) registered supplier status for the Netherlands. This certification powerfully demonstrates Echoworx’s commitment to the highest standards of security and compliance. This achievement expands on the company’s existing FSQS certification for the UK and Ireland, secured in 2020. By successfully completing the rigorous qualification for the Netherlands, Echoworx reinforces its alignment with the stringent demands of the European financial market. The FSQS system, managed by Hellios, provides a single, reliable standard for vetting third-party suppliers, streamlining procurement for major banks and financial institutions. Think of FSQS as a high-security passport for technology partners. It p
Nippon Electric Glass to Start World’s First Mass Production of Low-Carbon Pharmaceutical Glass Tubing Using an All-Electric Furnace16.12.2025 03:00:00 CET | Press release
Nippon Electric Glass Co., Ltd. (NEG)(TOKYO:5214), a global leader in specialty glass headquartered in Otsu, Japan, announced it will begin the world’s first mass production of pharmaceutical-grade glass tubing using an all-electric melting furnace. Commercial production is scheduled to start in December 2025 at its subsidiary in Selangor, Malaysia. This breakthrough introduces a new manufacturing model for pharmaceutical packaging. By combining NEG’s proprietary all-electric melting technology with renewable energy, CO2 emissions from glass tubing production can be reduced by up to 90%*1 compared with conventional fossil-fuel combustion furnaces. This positions NEG as a major supplier capable of delivering both high-performance borosilicate glass and a significantly lower carbon footprint, directly addressing global sustainability demands from pharmaceutical companies and regulators. NEG is a leading global supplier of arsenic-free, environmentally friendly borosilicate glass tubing f
Esco Aster Signs Exosome Clinical cGMP Manufacturing Contract With Shine-On Biomedical For A Novel First-In-Class HLA-G Targeting Exosome Drug Delivery Platform16.12.2025 02:00:00 CET | Press release
Esco Aster, a vertically integrated cell and derivatives CRDMO based at JTC LaunchPad Singapore, announced CMC manufacturing support for Shine-On Biomedical’s HLA-G targeted exosome program. Shine-On Biomedical sponsored Esco Aster in 2023 for cGMP services, starting with high-yield exosome development using Esco Aster’s cell line platform. The technical reports of process, analytical, and formulation development, exosome drug loading, GMP engineering runs, and stability studies supported Shine-On’s IND submission. The IND was cleared by the U.S. FDA in Q1 2025. Furthermore, Esco Aster is providing technical services for exploratory exosome loading feasibility studies per Shine-On’s instruction. Shine-On Biomedical is an emerging innovator in exosome-based drug delivery. ShineOn’s proprietary product, SOB100, a HLA-G targeted exosome drug delivery carrier, has passed the U.S. FDA IND review and ongoing Phase I study, making it as a first-in-class–potential HLA-G targeted exosome platfo
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
